MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents is a research paper published in Molecular Therapy — Nucleic Acids (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01HL123804
American Heart Association
Grant: 18CDA34110301
American Lung Association
Grant: RG-416135
Gilead Sciences
Grant: 1R56-HL141206-01
National Center for Advancing Translational Sciences
Grant: UL1TR002003
NHLBI NIH HHS
Grant: K08 HL133474
NHLBI NIH HHS
Grant: R56 HL141206
National Institutes of Health
Grant: 5R01HL123804-04
Role of microRNA-17-92 and PDLIM5 Signaling in Pulmonary Arterial Hypertension
National Institutes of Health
Grant: 5UL1TR002003-08
Clinical and Translational Science Award
National Institutes of Health
Grant: 1R56HL141206-01A1
Endothelium-derived Extracellular Vesicles, MicroRNAs and Pulmonary Hypertension
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals